Go Symbol Lookup
Loading...

Stop Trading!: Cramer's Healthcare Trio

 Text Size  
Published: Tuesday, 8 Jan 2008 | 3:39 PM ET
By:

Web Producer

Stop Trading, Listen to Cramer!
Mad Money host Jim Cramer shares his stock picks and pans with CNBC's Erin Burnett.


Cramer unveiled his three healthcare buys for 2008 on Tuesday’s Stop Trading!: St. Jude , Schering-Plough and MedcoHealth . All three should perform well even as the overall economy “sinks into a slow abyss,” he said.

He also took time to reiterate his recommendation of agriculture and seed superstar Monsanto . The stock is a buy into the presidential election, according to Cramer, because it is tied to the candidates’ needs to win farm states, as evidenced by their “ridiculous obsession” with ethanol.


Jim's charitable trust owns Schering-Plough and St. Jude

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

 Print
These three stocks should continue to profit in '08, Cramer says. Also, why Monsanto is a play on the election.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
  Price   Change %Change
MO ---
STJ ---

   
Comments

 

More Comments

 
 

Add Comments

 

Your Comments (Up to 1100 characters):

Remaining characters

Your comments have not been posted yet.

Please review your submission to make sure you are comfortable with your entry.

Your Comments:


                
            
            
        

Featured

Contact Mad Money

  • Showtimes

    Monday - Friday 6p | 11p ET
  • Cramer is host of CNBC's "Mad Money," and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.